Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Antonin Dréan"'
Autor:
Jean-Yves Delattre, Maite Verreault, Charlotte Schmitt, Antonin Dréan, Ahmed Idbaih, Lauriane Goldwirt, Alexandre Carpentier, Michael Canney, Jeremy Guehennec
Publikováno v:
Expert Review of Neurotherapeutics
Expert Review of Neurotherapeutics, Expert Reviews (formerly Future Drugs), 2016, 16 (11), pp.1285-1300. ⟨10.1080/14737175.2016.1202761⟩
Expert Review of Neurotherapeutics, 2016, 16 (11), pp.1285-1300. ⟨10.1080/14737175.2016.1202761⟩
Expert Review of Neurotherapeutics, Expert Reviews (formerly Future Drugs), 2016, 16 (11), pp.1285-1300. ⟨10.1080/14737175.2016.1202761⟩
Expert Review of Neurotherapeutics, 2016, 16 (11), pp.1285-1300. ⟨10.1080/14737175.2016.1202761⟩
International audience; Introduction: Glioblastomas (GBM) are the most common and aggressive primary malignant brain tumors in adults. The blood brain barrier (BBB) is a major limitation reducing efficacy of anti-cancer drugs in the treatment of GBM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b824249b23ea0a6e1b0157aada151f
https://hal.sorbonne-universite.fr/hal-01414544/file/Drean_2016_Blood-brain.pdf
https://hal.sorbonne-universite.fr/hal-01414544/file/Drean_2016_Blood-brain.pdf
Autor:
Karima Mokhtari, Antonin Dréan, Charlotte Schmitt, Franck Bielle, Maite Verreault, Aravindan Arun Nadaradjane, François-Xavier Lejeune, Marc Sanson, Ahmed Idbaih, Shai Rosenberg, Jeremy Guehennec, Alexandre Carpentier, Jean-Yves Delattre, Larissa Goli
Publikováno v:
Journal of Neuro-Oncology. 138:487-487
The names of authors Marc Sanson and Jean-Yves Delattre were incorrectly presented in the initial online publication. The original article has been corrected.